Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-25 @ 4:08 PM
Study NCT ID:
NCT05491057
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-08-08
First Post:
2022-07-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment Patterns of Neratinib in HER2+ EBC in China
Sponsor:
Pierre Fabre Medicament
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-27
First Submit QC Date:
None
Study First Post Date:
2022-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-04
Last Update Post Date:
2022-08-08
Last Update Post Date Type:
ACTUAL